Table of Contents Table of Contents
Previous Page  336 / 916 Next Page
Information
Show Menu
Previous Page 336 / 916 Next Page
Page Background

S332

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S303–S364

disorder or bipolar I disorder were enrolled in this study, from the

community mental health department of Ferrara.

Results

The tests were administered to 110 patients (mean age:

45

±

11,4) and to 86 controls (mean age: 35

±

12,6) of both sex. SCIP

presents high correlation with the R-BANS total score (

P

< 0.01) and

the subscales (verbal learning test-immediate, working memory,

verbal fluency test, verbal learning test-delayed, processing speed

test,

P

< 0.01). There are significant differences (

P

< 0.01) in all SCIP

dimensions between patient and control group

( Table 1 ).

Conclusions

Our analysis confirm the results of the English,

French and Spanish version of the SCIP regarding convergent and

discriminant validity. The SCIP represents a valid, simple and

brief screening tool for the cognitive evaluation of patients with

schizophrenia-spectrum disorders.

Table 1

VLT-I: verbal learning test-immediate; WMT: working

memory test; VFT: verbal fluency test; VLT-D: verbal learning

test-delayed; PST: processing speed test; R-BANS: repeatable

battery for the assessment of neuropsychological status;

TMT: trail making test; WCST: Wisconsin card sorting test.

P

< 0.01.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.02.274

EW0661

Effects of switching antipsychotics in

80 outpatients: A descriptive analysis

from a mental health community

R. Medina Blanco

, R. Martín Gutiérrez , M.J. Cuesta Nu˜nez ,

D. Sierra Biddle , P. Suárez Pinilla

Hospital universitario marqués de Valdecilla, psychiatry, Santander,

Spain

Corresponding author.

Introduction

In the general practice, psychiatrists widely pres-

cribe antipsychotics for several conditions as schizophrenia, bipolar

disorder and behavioral disorders among others.

Aim and objectives

The aim of this study is to describe the cli-

nical and sociodemographic features of typical patients receiving

antipsychotics and their effects after switching to long-acting treat-

ment.

Methods

A descriptive analysis of 80 outpatients collected from

a mental health clinic in Santander (Spain) was performed. All

patients were taking antipsychotics at baseline, both oral and

intramuscular, and were switched to a different long-acting anti-

psychotic drug.

Results

At baseline, 24 patients were taking oral medication and

56 intramuscular. There were 37 females and 43 males. There

were no gender differences in the final treatment, but Palmi-

tate Paliperidone (71.3%) was the most prescribed drug, followed

by intramuscular risperidone (16.3%) and long-acting aripipra-

zole (11.3%). We found gender differences regarding cannabis

(

P

= 0.002), alcohol (

P

= 0.004) and tobacco (

P

= 0.043) consumption,

being their use more common in males. In regard to diagnosis,

schizophrenia was predominant in both gender groups, whereas

delusional and behavioral disordersweremore frequent in females.

There were no significant differences in the reason of switching,

but the inefficacy was more common in males and the side effects

in females. At the switching, females were significantly older than

males (

P

= 0.003). We found significant differences before and after

switching regarding the number of admissions, emergency visits

and length of stay.

Conclusions

Antipsychotic benefits are individual and unpredic-

table. When switching, some other different factors should be

taking in account, not only regarding medication.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.02.275

EW0662

Association between smartphone

addiction proneness and poor sleep

quality in korean university students

K.B. Min

1 ,

, M. Jin-young

2

, K. Hyun-Jin

2

, K. Hye-Jin

3

1

College of medicine, Seoul national university, department of

preventive medicine, Seoul, Republic of Korea

2

Seoul national university, institute of health and environment,

Seoul, Republic of Korea

3

Seoul national university, school of public health, Seoul, Republic of

Korea

Corresponding author.

Background

The number of Korean smartphone users exceeded

40million in 2015, inwhich roughly 1 in 5 university students were

expected to be addicted to their smartphone. Of importance is that

smartphone addiction negatively affects physical and mental well-

being and health. Sleep problems associated with smartphone is

also a serious public concern; but the evidence is lacking. The aim

of this study is to investigate the association between smartphone

addiction proneness and sleep problems in Korean university stu-

dents.

Methods

We conducted an online-survey which received res-

ponses from 608 university students. All participants completed

questionnaires on the Korean smartphone addiction scale (K-SAS),

the Pittsburgh Sleep Quality Index (PSQI), and personal characte-

ristics. Based on the scores of the K-SAS, university students were

classified into two groups–the addiction proneness group and the

normal-user group.

Results

The addiction proneness groups had a higher PSQI score

than the normal-user group (7.5 vs. 6.7,

P

-value < 0.0001). After

adjustment for potential covariates (i.e., age, income, and smoking),

PSQI scores was significantly increased in the addiction proneness

groups (Beta coefficient = 0.69; 95%CI : 0.29

1.09). The risk of sleep

problems was more increased in the addiction proneness groups

(odds ratio = 1.99; 95% CI: 1.33

2.98) than the normal-user groups.

Conclusion

We found that the smartphone addiction prone-

ness was associated with sleep problems in university students.

Although our findings are further confirmed by elucidating causal

relationships between smartphone uses and sleep habits, smart-

phone addiction proneness may be a risk factor for poor sleep

quality.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.02.276

EW0663

Methylphenidate challenge followed

by therapeutic drug monitoring in

adults with attention

deficit/hyperactivity disorder:

Clinical effects and its predictors